Display options
Share it on

United European Gastroenterol J. 2020 Aug;8(7):753-754. doi: 10.1177/2050640620942641. Epub 2020 Jul 08.

Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease?.

United European gastroenterology journal

Vince Bc Biemans, Bram Verstockt

Affiliations

  1. Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  2. Department of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastrict, The Netherlands.
  3. Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
  4. Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.

PMID: 32640933 PMCID: PMC7434994 DOI: 10.1177/2050640620942641

[No abstract available.]

References

  1. Therap Adv Gastroenterol. 2019 May 26;12:1756284819853208 - PubMed
  2. N Engl J Med. 2017 May 4;376(18):1723-1736 - PubMed
  3. Clin Gastroenterol Hepatol. 2019 Apr;17(5):988-990.e1 - PubMed
  4. Aliment Pharmacol Ther. 2020 May;51(9):880-888 - PubMed
  5. Clin Gastroenterol Hepatol. 2020 Sep;18(10):2179-2191.e6 - PubMed
  6. Gut. 2017 Jun;66(6):1049-1059 - PubMed
  7. Nat Rev Gastroenterol Hepatol. 2020 Jun;17(6):323-337 - PubMed
  8. Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S53-S70 - PubMed
  9. United European Gastroenterol J. 2020 Aug;8(7):755-763 - PubMed

Substances

MeSH terms

Publication Types